Sandbox:Fahimeh: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
Line 11: Line 11:
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;|Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;|Additional findings
|-
|-
| rowspan="3" |'''History'''
| rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''History'''
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Symptoms'''
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Symptoms'''
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
Line 37: Line 37:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 56: Line 56:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Idiopathic/Viral
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Idiopathic/Viral
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 75: Line 75:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post cardiac surgery
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post cardiac surgery
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 94: Line 94:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 113: Line 113:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Connective tissue disease
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Connective tissue disease
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 132: Line 132:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignancy
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 151: Line 151:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mesothelioma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mesothelioma]]
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 170: Line 170:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic [[renal failure]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic [[renal failure]]
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 189: Line 189:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Asbestosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Asbestosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 210: Line 210:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Amyloidosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Amyloidosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 229: Line 229:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 248: Line 248:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemochromatosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemochromatosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 267: Line 267:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sclerodema
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sclerodema
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 286: Line 286:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endomyocardial fibrosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endomyocardial fibrosis
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 305: Line 305:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid heart disease
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid heart disease
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 324: Line 324:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 343: Line 343:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diabetic cardiomyopathy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diabetic cardiomyopathy
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 362: Line 362:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hurler
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hurler
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 381: Line 381:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gaucher
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gaucher
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 400: Line 400:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fabry
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fabry
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 419: Line 419:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wegener
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wegener
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 438: Line 438:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastatic malignancies
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastatic malignancies
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Latest revision as of 23:41, 27 February 2020


Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
History Symptoms Physical examination
Lab Findings Imaging Histopathology
Chest pain Fever Cough Edema/Ascites JVP Heart/Lung sounds Hepatosplenomegaly Lab 1 Lab 2 Lab 3 CT Scan MRI Echo/Sono
Constrictive pericarditis
Tuberculosis
Idiopathic/Viral
Post cardiac surgery
Post radiation
Connective tissue disease
Malignancy
Mesothelioma
Chronic renal failure
Asbestosis
Restrictive cardiomyopathy
Amyloidosis
Sarcoidosis
Hemochromatosis
Sclerodema
Endomyocardial fibrosis
Carcinoid heart disease
Post radiation
Diabetic cardiomyopathy
Hurler
Gaucher
Fabry
Wegener
Metastatic malignancies



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




References


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Fahimeh&oldid=1600745"